MolDX: Minimal Residual Disease Testing for Cancer (L38816) - R1 - Effective January 2, 2022

Date Posted: October 9, 2025

This MolDX Local Coverage Determination (LCD) has been revised under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: January 2, 2022

Summary of Changes:

Under Coverage Indications, Limitations and/or Medical Necessity: Indications: Formatting, punctuation, and typographical errors were corrected throughout the LCD.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCD or access it via the CMS Medicare Coverage Database (MCD).

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )